Ekonomi Bölümü Koleksiyonu
Permanent URI for this collectionhttps://hdl.handle.net/20.500.11779/1936
Browse
49 results
Search Results
Book Part Citation - Scopus: 2New Money: Central Bank Digital Currencies(Peter Lang AG, 2019) Karamollaoğlu, Nazlı; Tuncay, BernaPayment systems have been evolving along with technological advancements in the last couple decades. The introduction of different forms of electronic banking, the advance of Internet banking services, and advances in mobile phone and mobile payment technology have reduced the use of physical currency. Additionally, the first mover cryptocurrencies, bitcoin and its various alternatives (e.g., Ether, Litecoin), have been expanding their footprints, despite the volatility of their prices and the issues with their capability. These developments pose both opportunities and threats for Central Banks, particularly in the formulation of monetary policy and regulation of payment systems. Increased adoption of cryptocurrencies for payment transactions could undermine central banks' monetary policy missions as their policy power over the money in circulation would weaken. Weakened monetary policy control on the central bank side would risk financial stability. On the other hand, cryptocurrencies may also have positive impacts on the economy through various channels such as cost and time driven payment market efficiencies, financial inclusion, cashless society, and smaller informal sector. A central bank digital currency (CBDC) may have various characteristics related to its store of value, availability, settlement time, wallet and transaction limits, extent of use, being interest bearing or not and level of anonymity. While each characteristic has its own pros and cons, decisions on the CBDC characteristics need to be made by taking into account the country's circumstances, priorities, and ultimate policy objectives. © Peter Lang GmbH Internationaler Verlag der Wissenschaften Berlin 2019. All rights reserved.Book Part Mathematics for Social Sciences(Emerald Group Publishing Limited, 2016) Öztürk, MuratAll students enrolled in Business and Economics programs receive basic tarining in quantative methods used in subject that required mathematics and statistics.Article Article Citation - Scopus: 24Epidemiology and Economic Burden of Serotonin Syndrome With Concomitant Use of Serotonergic Agents: a Retrospective Study Utilizing Two Large Us Claims Databases(Physicians Postgraduate Press Inc., 2017-12-28) Alley, Stephanie; Nguyen, Charles T.; McCarron, Robert M.; Wang, Zhixiao; Xie, Lin; Başer, OnurObjective: Serotonin syndrome (SS) is an adverse drug reaction occurring among patients receiving serotonergic agents (SAs), and although SAs are commonly prescribed, the epidemiology and economic burden of SS with concomitant SA use have not been comprehensively examined. The objective of this study was to investigate the prevalence, incidence, and economic burden of SS with SA use. Methods: A retrospective cohort study was conducted using Veterans Health Administration (VHA) records (identification period: October 1, 2008-September 30, 2012) and commercially insured patient records (Intercontinental Marketing Services PharMetrics Plus; identification period: January 1, 2010-December 31, 2013). Cohorts were based on drug classification and exposure: single monoamine oxidase inhibitor (MAOI), MAOIs in combination with SAs, single non-MAOI SA, and multiple non-MAOI SAs (2, 3, 4, ? 5). Participants were aged ? 18 years with continuous health plan enrollment for 12 months prior to the first SA claim. Outcomes were SS events (ICD-9-CM: 333.99), annual incidence and prevalence, related health care utilization and costs, and SS incidence relative risk. Results: Over 15 million patients were identified and categorized by SA prescription type. SS incidence in both populations decreased: 0.19%-0.07% (VHA) and 0.17%-0.09% (commercially insured). Overall SS prevalence decreased during the study period. Compared to single non-MAOI SA patients, SS incidence relative risk was highest among patients prescribed ? 5 non-MAOI SAs. Inpatient stays accounted for 4.35% (VHA) and 0.88% (commercially insured) of all SS events. Of SS-related inpatient stays, median costs were $8,765 (VHA) and $10,792 (commercially insured). Conclusions: SS incidence and prevalence and SS-related hospitalization risk among patients prescribed SAs were low in both populations. This study provides additional information regarding SS risk associated with SA use. © 2017, Physicians Postgraduate Press Inc. All rights reserved.Book Part Fayda, Sosyal Seçim ve Mutluluk. Kitap Bölümü(İmge Kitabevi Yayınları, 2015) Gökdemir, Özge; Öztürk, Murat...Conference Object Psy14 - Evaluating Trends in Chronic Pain Prevalence in the United States Veterans Health Administration Population(Elsevier Science Inc, 2015-05-01) Li, L.; Shrestha, S.; Başer, Onur; Yuce, H; Wang, LOBJECTIVES: The current study examined chronic pain prevalence in the U.S. Veterans Health Administration (VHA) population. METHODS: The study sample was based on the VHA Medical SAS Datasets from fiscal year 2008 through 2012. All patients diagnosed with chronic pain throughout the study period were identified using International Classification of Diseases, 9th Revision, Clinical Modification diagnosis codes 338.2 and 338.4. The variation in the prevalence of chronic pain was assessed and categorized according to the pain scale. Pain score was determined using a scale ranging from 0 to 10 as reported by patients using the following categories: 1 to 4: mild, 5 to 6: moderate and ?7: severe pain. To identify prior prevalence cases, we restricted continuous enrollment throughout that fiscal year and at least 2 years priorConference Object Conference Object Long-Term Increased Inpatient and Outpatient Visits Associated With Cardiovascular Events: a Large United States Real World Study(2015) Fox, Kathleen M; Wang, L; Quek, RGW; Gandra, SR; Li, L; Başer, OnurConference Object Mortality and Prevalence of Major Depressive Disorder in the Us Medicare Population From 2008-2013(2016) Bashyal, R; Du, H; Wang, L; Yuce, H; Başer, Onur...Conference Object Assessing the Economic Burden and Health Care Utilization of Attention Deficit/Hyperactivity Disorder Among Us Medicaid Patients(2016) Zhang Q; Zhao, Y; Keshishian, A; Xie, L; Yuce, H; Başer, Onur...